Home » Topics » BioWorld

BioWorld
RSS

ORGANOGENESIS TO EXPAND TRIALS

Feb. 5, 1992

CENTOCOR ACQUIRES DIAGNOSTICS COMPANY

Feb. 5, 1992

UNIVAX IPO RAKES IN $48 MILLION

Feb. 5, 1992

ADVANCED POLYMER NETS $8.74 MILLION

Feb. 5, 1992

ANALYSTS RAISE AMGEN ESTIMATES

Feb. 5, 1992

ATRIX TO DELAY PERIODONTAL DRUG NDA

Feb. 5, 1992

LA JOLLA PHARM. RAISES $14 MILLION

Feb. 5, 1992

U.S. BIO PLANS FEBRUARY MEETING WITH FDA

Feb. 5, 1992

ANALYSTS QUESTION U.S. BIO STOCK TRADING

Feb. 5, 1992

U.S. BIO PLUNGES AFTER FDA REBUFF

Feb. 4, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...